
Commentary|Podcasts|December 22, 2023
Independent Rx Forum: Legal Frontiers and Updates From NCPA
Tune in to this episode of the Independent Rx Forum for a comprehensive update on legal developments and insightful discussions on class action lawsuits and regulatory guidelines from the National Community Pharmacists Association.
Advertisement
Host Jack Mozloom, vice president of Public Affairs and Marketing at the National Community Pharmacists Association (NCPA), speaks with Matthew Seiler, RN, Esq, general counsel at NCPA. The discussion spans recent legal developments, including a new class action lawsuit, updates on the Federal Trade Commission and Department of Justice's merger guidelines, insights into the NCPA Trust, and a crucial meeting with State Attorneys General.
Key Takeaways
- A new class action lawsuit has potential implications for independent pharmacies, and Matthew Seiler provides insights into its details.
- The discussion sheds light on their potential impact of the updated merger guidelines from the FTC and DOJ.
- The NCPA Trust continues to be a crucial player in safeguarding the interests of independent pharmacies. Learn more
here . - Engaging with State Attorneys General can help address legal matters impacting independent pharmacies.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
What Pharmacists Need to Know About Retatrutide's TRIUMPH-1 Phase 3 Results
2
FDA Approves Ensitrelvir for Post-Exposure Prophylaxis of COVID-19 in Adolescents and Adults
3
Why Some Patients Do Not Respond to GLP-1 Therapies
4
GIRE Combination Shows PFS Benefit in First-Line Metastatic Breast Cancer Treatment, Earning FDA Priority Review
5








































































































































